Exceeding Expectations For Patient Enrollment Case Study

   

 When Veristat partnered with a US based biotechnology company on a Phase II study for a topical spray to treat hypertension, our emphasis on effective planning and management led to overwhelming success. Find out how Veristat set-up and efficiently executed a Phase II safety & efficacy study all the way to regulatory submissions on an accelerated timeline.